| Pleural Malignant Mesothelioma studied in …STUDIED_INderived118 of 118show fewer |
|---|
| → studied in | NCT06037941NA · recruiting Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06318286Phase 2 · active not recruiting Study of Pembrolizumab Plus Chemotherapy With Lenvatinib for Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03074513Phase 2 · active not recruiting Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors · condition mapped CURATED_BROADER · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04162015Phase 1 · active not recruiting A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01064648Phase 1/Phase 2 · active not recruiting Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma · condition mapped ONTOLOGY_EXACT · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05647265Phase 2 · recruiting Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma · condition mapped ONTOLOGY_EXACT · 118 trials mapped (27 active) | — | — | Pleural Biphasic Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03228537Phase 1 · active not recruiting Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma · condition mapped CURATED_BROADER · 118 trials mapped (27 active) | — | — | Pleural Diffuse Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02535312Phase 1/Phase 2 · active not recruiting Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin · condition mapped CURATED_BROADER · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04491942Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer · condition mapped CURATED_BROADER · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04577326Phase 1 · active not recruiting Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05278975Phase 1/Phase 2 · completed Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03917043Phase 1 · recruiting APG-2449 in Patients With Advanced Solid Tumors · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04158141Phase 3 · terminated Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma · condition mapped CURATED_BROADER · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06756035Phase 1 · recruiting CT-95 in Advanced Cancers Associated With Mesothelin Expression · condition mapped CURATED_BROADER · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05765084Phase 1/Phase 2 · recruiting Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02959463Phase 1 · completed Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma · condition mapped ONTOLOGY_EXACT · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02399371Phase 2 · completed Pembrolizumab in Treating Patients With Malignant Mesothelioma · condition mapped ONTOLOGY_EXACT · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07561190recruiting Multidimensional Omics Analysis in Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07550049not yet recruiting Comprehensive Oncogenomic Mapping and Exploration in Thoracic and Head & Neck Oncology · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03710876Phase 3 · completed Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03126630Phase 1/Phase 2 · active not recruiting Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma · condition mapped ONTOLOGY_EXACT · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05655078NA · recruiting Hemithoracic Irradiation With Proton Therapy in Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04897022Phase 1 · active not recruiting A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00797719Phase 1/Phase 2 · completed Short Neoadjuvant Hemithoracic IMRT for MPM · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02662504Phase 2 · completed Intrapleural Photodynamic Therapy in a Multimodal Treatment for Patients With Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04166734Phase 1 · terminated Pembrolizumab and Hypofractionated Stereotactic Radiotherapy in Patients With Malignant Pleural Mesothelioma · condition mapped CURATED_BROADER · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04334759Phase 3 · completed DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03269227NA · active not recruiting Accelerated Hypofractionated Radiotherapy in the Treatment of Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02611037Phase 2 · completed Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05795595Phase 1/Phase 2 · completed A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05308966completed Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE) · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04400539Phase 2 · recruiting The IMmunotherapy Pleural 5-ALA PDT · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02863055Phase 2 · terminated Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05107674Phase 1 · recruiting A Study of NX-1607 in Adults With Advanced Malignancies · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07121374Phase 1/Phase 2 · recruiting NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility Study · condition mapped ONTOLOGY_EXACT · 118 trials mapped (27 active) | — | — | Pleural Epithelioid Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04525859Phase 1 · completed Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05188859Phase 2 · recruiting First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02649829Phase 1/Phase 2 · completed Autologous Dendritic Cell Vaccination in Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06910449NA · recruiting Hemithoracic Arc Radiotherapy Post Pleural Decortication · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06886672recruiting Genetic Susceptibility in MAlignant Pleural Mesothelioma: Clinical Implication of GermliNE variaTionS · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06726564Phase 1 · recruiting A Study of MT027 in Patients with Pleural Malignant Tumors · condition mapped ONTOLOGY_EXACT · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05228015Phase 1 · terminated Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04843007completed Alvopem® (Pemetrexed) Safety Assessment · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01265433Phase 2 · completed Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality Therapy · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05660616Phase 2 · completed Switch-Maintenance Gemcitabine After First-Line Chemotherapy In Patients With Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04480372Phase 2 · completed SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05425576Phase 2 · not yet recruiting OT-101 in Combination With Pembrolizumab in Subjects With Malignant Pleural Mesothelioma Failing to Respond to Checkpoint Inhibition · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02004028Phase 2 · terminated Window of Opportunity Study of VS-6063 (Defactinib) in Surgical Resectable Malignant Pleural Mesothelioma Participants · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05498597Phase 1 · unknown AMT-151 in Patients With Selected Advanced Solid Tumours · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06031636unknown Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in Patients With Advanced Malignant Pleural Mesothelioma · condition mapped CURATED_BROADER · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01486368Phase 2 · completed A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05582031Phase 2 · withdrawn Regorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable Cancers · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02555007Phase 1 · completed Metronomic Chemotherapy Based on Adaptative Bio-mathematical Model of Oral Vinorelbine in Patients With NSCLC or MPM · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02436733Phase 2 · unknown Pleurectomy/ Decortication (P/D) Preceded or Followed by Chemotherapy in Patients With Early Stage MPM · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00652574Phase 1 · completed Dasatinib in Resectable Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00738582Phase 2 · completed An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01865045completed Pharmacogenetics Of Vinorelbine In Malignant Pleural Mesothelioma Patients · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05508555NA · unknown Effect of HITHOC After Pleurectomy Decortication for Treatment of Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04013334Phase 2 · unknown MTG201 Plus Nivolumab in Patients With Relapsed Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02347917Phase 1/Phase 2 · completed A Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04775446completed Evaluation of the Clinical/Biological Characteristics, Efficacy and Safety of Patients With Malignant Pleural Mesothelioma, Treated by Immunotherapy · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02568449Phase 2 · completed Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent · condition mapped CURATED_BROADER · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01644994Phase 1/Phase 2 · completed Intracavitary Cisplatin-Fibrin Localized Chemotherapy After P/D or EPP for Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02408016Phase 1/Phase 2 · terminated Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma · condition mapped CURATED_BROADER · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05042557unknown Real World Study of MPM in China · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00700336Phase 1/Phase 2 · completed Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II) · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213301Phase 2 · completed Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma. · condition mapped CURATED_BROADER · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03786419Phase 2 · withdrawn A Study of Atezolizumab in Unresectable or Advaced Malignant Pleural Mesothelioma · condition mapped CURATED_BROADER · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04713761Phase 2 · unknown Neoadjuvant Toripalimab Combined With Chemotherapy in the Treatment of Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02049060Phase 1/Phase 2 · completed Study of the Combination of Tivantinib Plus Pemetrexed and Carboplatin · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03048474Phase 2 · completed Ipilimumab and Nivolumab in the Treatment of Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04201145Phase 1 · withdrawn Pembrolizumab + Defactinib In Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01675765Phase 1 · completed Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03177668Phase 1/Phase 2 · completed Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03412357NA · completed MesoTRAP: A Study Comparing Video-assisted Thoracoscopic Partial Pleurectomy/Decortication With Indwelling Pleural Catheter in Patients With Trapped Lung Due to Malignant Pleural Mesothelioma. · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02672033NA · terminated Accelerated Hypofractionated Radiation Therapy Immediately Before Surgery in Treating Patients With Malignant Pleural Mesothelioma · condition mapped ONTOLOGY_EXACT · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01773655completed Clinical and Histopathologic Characteristics of BAP1 Mutations · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01112293Phase 2 · completed Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma · condition mapped ONTOLOGY_EXACT · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01143545Phase 1 · terminated Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02194231Phase 2 · completed ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM) · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01098266Phase 3 · completed NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01722149early Phase 1 · completed Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03175172Phase 2 · terminated Evaluation of CRS-207 With Pembrolizumab in Previously Treated Malignant Pleural Mesothelioma (MPM) · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00484276Phase 2 · completed Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01358084Phase 2 · completed Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced MPM · condition mapped CURATED_BROADER · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02397928Phase 2 · completed Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignant Pleural Mesothelioma (STELLAR) · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02661659Phase 1 · withdrawn A Phase Ib Trial of a Maintenance Multipeptide Vaccine (S-588210) in Patients With Unresectable Malignant Pleural Mesothelioma Without Progression After First-Line Chemotherapy · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02761863unknown Effect of Expression of CD74 and VEGF on Outcome of Treatment in Patients With Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02269878completed Effect of FAS and FAS Ligand Polymorphisms on Patients With Platinum-Based -Treated Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03290183unknown Confocal Laser Endomicroscopy in Pleural Malignancies · condition mapped ONTOLOGY_EXACT · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01355965Phase 1 · completed Autologous Redirected RNA Meso-CIR T Cells · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02497508Phase 2 · completed Nivolumab in Patients With Recurrent Malignant Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01721018Phase 1/Phase 2 · completed Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma. · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02369198Phase 1 · completed MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLC · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01869023Phase 2 · unknown Phase II Study of Six Hours Low Dose Gemcitabine Plus Cisplatin in the Treatment for Advanced Pleural Mesothelioma · condition mapped CURATED_BROADER · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01211275Phase 1/Phase 2 · completed Standard Chemotherapy With of Without Axitinib in Malignant Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01870609Phase 2 · terminated Placebo Controlled Study of VS-6063 in Subjects With Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00571298Phase 1 · completed Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02639767Phase 1 · withdrawn Concurrent Pemetrexed/Cisplatin With Pleural Intensity Modulated Radiation Therapy for Patients With Unresectable Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02755675Phase 2 · unknown uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00165503Phase 2 · terminated Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01212367Phase 1 · completed Intrapleural Gene Transfer for Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01769547Phase 2 · terminated A Phase II Study of Single-agent DOVitinib in Advanced Malignant PlEural Mesothelioma Which Has Progressed Following Prior Platinum-Antifolate Chemotherapy · condition mapped CURATED_BROADER · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00969098unknown Response Evaluation in Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02497053Phase 2 · unknown Four Versus Six Cycles of Pemetrexed/Platinum for MPM · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01024946Phase 2 · completed Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00867711completed Molecular Predictors of Pemetrexed and Carboplatin Response in Malignant Pleural Mesothelioma (MPM) Patients · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01279967Phase 2 · unknown A Clinical Trial of ADI-PEG 20TM in Patients With Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00165516Phase 2 · completed Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00165555Phase 1 · completed Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01241682Phase 1 · completed Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01353482Phase 1/Phase 2 · withdrawn A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01343264unknown Trimodality Therapy for Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01243632Phase 2 · completed Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma Treatment · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00280982Phase 1 · completed Dendritic Cell-based Immunotherapy in Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00272558Phase 2 · completed Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00886028Phase 2 · unknown Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00386815Phase 2 · completed Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma · condition mapped ALIAS · 118 trials mapped (27 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |